Internal Medicine, Pulmonary Disease · Maywood, IL
NPI
1669407912
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
2160 S First Ave, (17w740 22nd Street, Oakbrook Terrace, Il. 60181)
Maywood, IL, 60153
Phone (630) 627-7399
Groups this clinician bills Medicare through
Medicare paid, 2024
$72K
716 services
Medicare patients, 2024
182
Average age 68
Drug cost, 2024
$9.1M
3,360 prescriptions
Company payments, 2025
$150
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James P Gagermeier was code 99215 (office e&m - established), 252 times for 101 patients. In total James P Gagermeier billed 716 services in 29 codes, and Medicare paid $72K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-05-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 252 | 101 | $112.91 | $28K |
| 99233 Hospital E&M - Subsequent | Facility | 165 | 41 | $96.29 | $16K |
| 99291 Critical Care E&M | Facility | 98 | 36 | $176.13 | $17K |
| 94375 Pulmonary Function Testing | Facility | 82 | 36 | $10.77 | $883 |
| 31628 Bronchoscopy | Facility | 27 | 19 | $127.30 | $3,437 |
| 99152 Anesthesia | Facility | 22 | 16 | $10.28 | $226 |
| 99205 Office E&M - New | Facility | 12 | 12 | $136.47 | $1,638 |
By year: 2022 $100K for 974 services; 2023 $100K for 952 services; 2024 $72K for 716 services.
Medicare prescription drug claims, 2024
In 2024, the drug James P Gagermeier prescribed most often to Medicare patients was Azithromycin, with 250 prescriptions and refills. In total James P Gagermeier wrote 3,360 Medicare prescriptions that cost $9.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Azithromycin Generic | 250 | 448 | 58 | $4,077 |
| Furosemide Generic | 191 | 348 | 49 | $918 |
| Prednisone Generic | 153 | 259 | 36 | $1,116 |
| Opsumit Macitentan | 120 | 120 | 17 | $1.5M |
| Sildenafil Citrate Generic | 119 | 133 | 24 | $14K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 112 | 263 | 32 | $643 |
| Tacrolimus Generic | 109 | 189 | 16 | $19K |
| Uptravi Selexipag | 104 | 104 | 13 | $2.4M |
| Pantoprazole Sodium Generic | 100 | 233 | 32 | $1,416 |
| Adempas Riociguat | 93 | 93 | 13 | $1.2M |
| Ambrisentan Generic | 88 | 88 | Under 11 | $291K |
| Montelukast Sodium Generic | 77 | 193 | 23 | $1,251 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 66 | 93 | 18 | $2,121 |
| Potassium Chloride Generic | 64 | 103 | 21 | $3,079 |
| Tadalafil Generic | 59 | 59 | Under 11 | $62K |
Brand drugs: - claims; generic drugs: 2,613 claims; opioid claims: 19.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James P Gagermeier $150 ($150 in general payments such as food, travel and fees) from 1 company. The largest payer was United Therapeutics Corporation with $150.
| Company | Payments | Amount |
|---|---|---|
| United Therapeutics Corporation UTHR | 1 | $150 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.